Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transplantation of Mesenchymal Stem Cells for Prevention of Acute Myocardial Infarction Induced Heart Failure: a Phase III Randomized Clinical Trial

NCT05043610 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.

NCT NCT05043610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transplantation of Mesenchymal Stem Cells for Prevention of Acute Myocardial Infarction Induced Heart Failure: a Phase III Randomized Clinical Trial
Lead sponsor
Shiraz University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2021
Completion date
November 1, 2024
Enrollment
420 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac remodeling, ventricular, heart failure, myocardial infarction first, myocardial infarction, acute, myocardial infarction, anterior wall, regenerative medicine, stemi